USA Change Macroaxis User Registration

Home Portfolios Solutions About Us

More ROI Blog

Market Overview ScreenersIndustriesCompanies Community Investment Grader

US Market Open: Feb 9, 16:08 PM 2012

NYSE 8078.16 4.82 Index Moved Down

NASDAQ 2927.23 11.37 Index Moved Up

and more..

sponsered by

Processing
Collecting necessary data for ACUR and FLML...

Asset Comparison and Correlation

View All Portfolios

More Actions
- Select Assests
- Optimize Portfolio
- Suggest Portfolio
- Backtest Watchlist
- Analyze Correlations
- View Transactions
- Check Volatilities
- Import Equities
- Search Equities
- Filter Tops

Acura Pharmaceuticals Inc. and

Flamel Technologies S.A.

Volatility

Matrix

Run Correlation

Diversification

Very good diversification

Overlapping area represents amount of risk that can be diversified away by holding Acura Pharmaceuticals Inc. and Flamel Technologies S.A. in the same portfolio (assuming nothing else is changed)

Optimize

Correlation Coefficient

-0.38

Parameters

Time Period	1 Month [change]
Direction	Negative
Strength	Insignificant
Accuracy	95.45%
Values	Daily Returns

Suggest

Acura Pharmaceuticals Inc.

Profile

3.25

Intraday

One Month

^0.02

0.62%

ACUR

NCM

Acura Pharmaceuticals Inc.

P/E	16.91	Day Low	3.20
Open	3.26	P/B Ratio	3.85
Market Cap	147.3M	Volume	58166
Sector	Healthcare	Last Close	3.23
Short Ratio	27.30	Last Traded	2/9/2012
Year High	6.80	Percent Change	0.62%
EBITDA	9.6M	Year Low	2.28
Absolute Change	0.02	Time	Not Applicable
Book Value	0.838	EPS	0.191
Day High	3.31	Industry	Drug Delivery
Target Price	8.00	Current EPS	0.191
Current PE	16.91	This Year PE	Not Applicable

Flamel Technologies S.A.

Profile

6.65

Intraday

One Month

^0.07

1.06%

FLML

NGM

Flamel Technologies S.A.

Day Low	6.575	Open	6.68
P/B Ratio	5.01	Market Cap	163.9M
Volume	78905	Sector	Healthcare
Last Close	6.58	Founded	Yes
Short Ratio	1.00	Last Traded	2/9/2012
Year High	7.35	Percent Change	1.06%
EBITDA	-1.4M	Year Low	3.61
Absolute Change	0.07	Time	Not Applicable
Book Value	1.313	EPS	-0.162
PEG Ratio	0.20	Employees	291
Day High	6.69	Industry	Drug Delivery
Target Price	12.00	Current EPS	-0.162
This Year EPS	-0.17	Next Year EPS	0.51
Next Year PE	12.90	Dividend	Not Applicable